Top Markets
Coin of the day
FunPep Company Limited FunPep Company Limited

FunPep Company Limited

4881
Rang in Aktien #31111
FunPep Company Limited specializes in the discovery and advancement of... FunPep Company Limited specializes in the discovery and advancement of pharmaceutical drugs, functional cosmetics, and medical devices, leveraging its core technology in functional peptides. The company's development pipeline prominently features SR-0379, a functional peptide designed to address skin ulcers. FunPep is advancing FPP003, an antibody-inducing peptide, which is undergoing Phase II clinical trials for psoriasis in Australia and for ankylosing spondylitis in Japan. Another antibody-inducing peptide, FPP004X, is also in development, targeting pollinosis. Additionally, the company is working on FPP006, a corona peptide vaccine, and FPP005, an antibody-inducing peptide for psoriasis. Established in 2013, FunPep Company Limited operates from its headquarters in Tokyo, Japan.
Aktienkurs
$0.31969414
Marktkapitalisierung
$14.34M
Veränderung (1 Tag)
-3.92%
Veränderung (1 Jahr)
-60.01%
Land
JP
Handel FunPep Company Limited (4881)

Kategorie

Dividendenrendite-Verlauf für FunPep Company Limited (4881)
Dividendenrendite (TTM) von FunPep Company Limited (Aktienkürzel: 4881) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für FunPep Company Limited (4881) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.48%
BE